Measuring body composition using the bioelectrical impedance method can predict the outcomes of gemcitabine-based chemotherapy in patients with pancreatobiliary tract cancer

In order to examine the effect on body composition of anticancer drug treatments, the body composition rate in patients being treated with gemcitabine (GEM)-based chemotherapy was measured over time on an outpatient basis with a simple body composition monitor using the bioelectrical impedance (BI)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Lett
Egile Nagusiak: MURAMATSU, MAMI, TSUCHIYA, AYA, OHTA, SEIKO, IIJIMA, YUKIE, MARUYAMA, MIYUKI, ONODERA, YOSHIKO, HAGIHARA, MEGUMI, NAKAYA, NAOKI, SATO, ITARU, OMURA, KENJI, UENO, SOICHIRO, NAKAJIMA, HIDEO
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665841/
https://ncbi.nlm.nih.gov/pubmed/26788165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3811
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak